Cargando…

Obinutuzumab/rituximab: Decreased platelet count and chronic COVID-19 pneumonia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728520/ http://dx.doi.org/10.1007/s40278-020-87403-5

Ejemplares similares

Bendamustine/obinutuzumab: COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report
Publicado: (2021)

Prednisone/rituximab: COVID-19 pneumonia: case report
Publicado: (2021)

Bendamustine/rituximab: COVID-19 pneumonia: case report
Publicado: (2021)

Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia
por: Genest, Dominique S., et al.
Publicado: (2021)

Immunosuppressants/rituximab: COVID-19-pneumonia: 2 case reports
Publicado: (2021)

Rituximab: Persistent COVID-19 pneumonia: 5 case reports
Publicado: (2022)

Obinutuzumab: B-cell depletion: case report
Publicado: (2021)

Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report
por: Lachowiez, Curtis, et al.
Publicado: (2017)

Cytarabine/dasatinib/rituximab: Reactivation of COVID-19 pneumonia : case report
Publicado: (2020)

Methotrexate/prednisone/rituximab: COVID-19 pneumonia: 3 case reports
Publicado: (2021)

Rituximab: Relapse or exacerbation of COVID-19 pneumonia: 4 case reports
Publicado: (2022)

Methotrexate/prednisolone/rituximab: COVID-19 pneumonia: 2 case reports
Publicado: (2021)

Daratumumab/obinutuzumab: Various toxicities: 14 case reports
Publicado: (2021)

GALLIUM trial: the tortoise (rituximab) and the hare (obinutuzumab) race
por: García-Muñoz, Ricardo, et al.
Publicado: (2019)

Bendamustine/obinutuzumab/remdesivir: Absence of CD19-B lymphocytes, decrease in CD4-T lymphocytes and lack of efficacy: case report
Publicado: (2021)

Covid-19-vaccine/tozinameran: Gastrointestinal internal bleed, blood clot and decreased platelet count: 4 case reports
Publicado: (2022)

Rituximab: COVID-19 pneumonia and herpes simplex virus infection: case report
Publicado: (2022)

Rituximab: COVID‐19 infection complicated by secondary organising pneumonia: case report
Publicado: (2022)

Prednisolone/rituximab: COVID-19 and SARS-CoV-2 pneumonia: case report
Publicado: (2021)

Rituximab: COVID-19: case report
Publicado: (2021)

Rituximab: COVID-19: case report
Publicado: (2022)

Rituximab: COVID-19: case report
Publicado: (2022)

Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
por: Khurana, Sharad, et al.
Publicado: (2019)

Methotrexate/rituximab/tozinameran interaction: Brain death secondary to the COVID-19 pneumonia: case report
Publicado: (2021)

Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab
por: Gaudêncio, Margarida, et al.
Publicado: (2021)

Rituximab: COVID-19: 2 case reports
Publicado: (2021)

Rituximab: COVID-19: 2 case report
Publicado: (2021)

Prednisone/rituximab: COVID-19: case report
Publicado: (2021)

Rituximab: COVID-19 infection: case report
Publicado: (2021)

Rituximab: COVID-19 infection: case report
Publicado: (2021)

Rituximab: COVID-19: 2 case reports
Publicado: (2022)

Rituximab: COVID-19 infection: case report
Publicado: (2022)

Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma
por: Ueda, Yayoi, et al.
Publicado: (2022)

Obinutuzumab in a patient with chronic lymphocytic leukemia-associated paraneoplastic pemphigus
por: Freund, Johanna, et al.
Publicado: (2022)

Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab
por: Franceschini, Erica, et al.
Publicado: (2023)

Chloroquine/favipiravir/rituximab: COVID-19-pneumonia, off-label use and lack of efficacy: case report
Publicado: (2022)

Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports
por: Lassandro, Giuseppe, et al.
Publicado: (2022)

Rituximab: SARS-CoV-2 pneumonia: case report
Publicado: (2021)

Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma
por: Spencer, Scott J, et al.
Publicado: (2021)

Rituximab: COVID-19 infection: 2 case reports
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kqlb5pru9quqa442o9hjc4sjfd